![Carol Brosgart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carol Brosgart
Direktor/Vorstandsmitglied bei
EOCENE LTD.
Vermögen: - $ am 31.08.2026
Profil
Carol L.
Brosgart was the founder of East Bay AIDS Center, founded in 1987, serving as Medical Director from 1987 to 1988.
Current jobs include Director at American Liver Foundation of Northern California, Director & Research Integrity Officer at Hepatitis B Foundation, Independent Director at Galmed Pharmaceuticals Ltd. since 2017, Director at A.P.
Giannini Foundation, Berkeley Community Fund, Pure Blue Diagnostics, Inc., and National Viral Hepatitis Roundtable, Director at MERLIN Biotech LLC since 2022, Director at Cocrystal Pharma, Inc. starting 2026, Professor at The University of California, San Francisco, and Research Integrity Officer at Baruch S.
Blumberg Institute.
Former jobs include Director at Juvaris BioTherapeutics, Inc., The San Francisco Aids Foundation, Pangaea Global Aids, and Intrivo Diagnostics; Independent Director at Tobira Therapeutics, Inc. from 2009 to 2016, Mirum Pharmaceuticals, Inc. from 2021 to 2022, Abivax SA from 2018 to 2024, and Lunai Bioworks, Inc. from 2019 to 2024; Medical Director at Central Health Center and Alameda County Health Care Services Agency from 1978 to 1987; Vice President-Public Health & Policy at Gilead Sciences, Inc. from 1998 to 2009; Chief Medical Officer at Alios BioPharma, Inc. in 2011; Chief Medical Officer & Senior Vice President at Children's Hospital Oakland Research Institute from 2009 to 2011.
Education includes undergraduate degree from the University of California, Berkeley and doctorate from The University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EOCENE LTD. -.--% | 25.03.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Carol Brosgart
| Unternehmen | Position | Beginn |
|---|---|---|
| EOCENE LTD. | Direktor/Vorstandsmitglied | 07.06.2017 |
| COCRYSTAL PHARMA, INC. | Direktor/Vorstandsmitglied | 12.08.2026 |
Berkeley Community Fund
 Berkeley Community Fund Berkeley Community Fund is a private company based in Berkeley, CA. | Direktor/Vorstandsmitglied | - |
National Viral Hepatitis Roundtable | Direktor/Vorstandsmitglied | - |
A.P. Giannini Foundation | Direktor/Vorstandsmitglied | - |
Baruch S. Blumberg Institute
 Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | Corporate Officer/Principal | - |
Pure Blue Diagnostics, Inc. | Direktor/Vorstandsmitglied | - |
American Liver Foundation of Northern California | Direktor/Vorstandsmitglied | - |
Hepatitis B Foundation
 Hepatitis B Foundation The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education, advocacy, and patient support. The non-profit company is based in Doylestown, PA. The foundation provides educational resources on hepatitis B prevention, diagnosis, treatment, and management, emphasizing vaccination, testing, and early intervention. It addresses special populations such as children and individuals coinfected with HIV, offers expert guidelines and support programs, combats stigma and discrimination, and advocates for patients’ rights. The foundation supports patients and healthcare providers with clinical trial information, physician directories, medication assistance, online support groups, and training programs. The company was founded by Joan M. Block, Timothy M. Block. Louis P. Kassa has been the CEO of the company since 2022. | Direktor/Vorstandsmitglied | - |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Carol Brosgart
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Carol Brosgart
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
25
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 25 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Develops novel and adjuvanted vaccines, immunotherapeutic to treat infectious disease & cancer | Health Technology |
American Liver Foundation of Northern California | |
The San Francisco Aids Foundation
 The San Francisco Aids Foundation Miscellaneous Commercial ServicesCommercial Services Provides education, advocacy and direct services for HIV prevention and care | Commercial Services |
Hepatitis B Foundation
Hepatitis B Foundation The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education, advocacy, and patient support. The non-profit company is based in Doylestown, PA. The foundation provides educational resources on hepatitis B prevention, diagnosis, treatment, and management, emphasizing vaccination, testing, and early intervention. It addresses special populations such as children and individuals coinfected with HIV, offers expert guidelines and support programs, combats stigma and discrimination, and advocates for patients’ rights. The foundation supports patients and healthcare providers with clinical trial information, physician directories, medication assistance, online support groups, and training programs. The company was founded by Joan M. Block, Timothy M. Block. Louis P. Kassa has been the CEO of the company since 2022. | |
Children's Hospital Oakland Research Institute
 Children's Hospital Oakland Research Institute Hospital/Nursing ManagementHealth Services Operates as a biomedical research institute of children's hospital and research center | Health Services |
Galmed Pharmaceuticals Ltd.
 Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis | Health Technology |
Cocrystal Pharma, Inc.
 Cocrystal Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for use in the treatment of human viral diseases | Health Technology |
Baruch S. Blumberg Institute
Baruch S. Blumberg Institute The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block. | |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
A.P. Giannini Foundation | |
East Bay AIDS Center
 East Bay AIDS Center Medical/Nursing ServicesHealth Services East Bay AIDS Center operates in the Hospitals & Physicians Clinics industry. The non-profit company is based in Oakland, CA. The company was founded by Carol L. Brosgart. | Health Services |
Central Health Center
 Central Health Center Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Alameda County Health Care Services Agency
 Alameda County Health Care Services Agency Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Berkeley Community Fund
Berkeley Community Fund Berkeley Community Fund is a private company based in Berkeley, CA. | |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Pangaea Global Aids
 Pangaea Global Aids Pangaea Global Aids is a private company based in Oakland, CA. | |
Pure Blue Diagnostics, Inc. | |
Intrivo Diagnostics
 Intrivo Diagnostics Information Technology ServicesTechnology Services Operates as a health care technology company that provides intuitive tools and comprehensive data | Technology Services |
National Viral Hepatitis Roundtable |
